Regeneron Secures $407M Jury Verdict in Major Antitrust Win
2 minute read | May.16.2025
This verdict will ensure that patients continue to have access to Regeneron’s lifesaving, cholesterol-reducing drug Praluent.
2 minute read | May.16.2025
This verdict will ensure that patients continue to have access to Regeneron’s lifesaving, cholesterol-reducing drug Praluent.
2 minute read | March.19.2025
2 minute read | May.16.2025
Orrick remains the #1 most active venture capital law firm in Europe. The firm also ranked #4 globally.